The Wisconsin Alumni Research Foundation and the Geron Corporation announced today that they had reached a patent licensing agreement that is expected to make it easier for other companies and academic scientists to develop medical treatments using human embryonic stem cells. The agreement settles a lawsuit between them and narrows the exclusive commercial rights that Geron has to embryonic stem cells.
Full story published in the New York Times, Jan 10, 2002.
Message posted by: Anthony W.I. Lo